The short answer
If multiple myeloma may have returned, ask what is confirmed, what is still uncertain, and which next steps change the plan.
NCI states that relapses occur for almost all patients after induction therapy, autologous transplant and maintenance. A rising number is the shape of the illness, not a failure.
With each successive relapse the monoclonal protein doubling time increases and remission durations get shorter, which is a reason to plan ahead rather than to rush.
A rise in numbers alone is not automatically a reason to treat: NCI notes therapy may be delayed when progression is slow and performance status is good.
Active disease is defined by specific findings — high calcium, creatinine above 2 mg/dL or clearance under 40 mL/min, hemoglobin under 10.0 g/dL, bone lesions, 60% or more clonal marrow plasma cells, or an involved:uninvolved free light chain ratio of 100 or more.
Choose how you want to understand this
The full explanation.
Relapse is expected, and that is not the same as failure
NCI puts it plainly. Relapses occur for almost everyone after induction treatment, a transplant and maintenance.
Reading that sentence early helps. A rising number is not a sign that something went wrong. It is the shape of this illness, and there is a plan for it.
What the numbers are telling you
Myeloma is usually followed with blood tests, so relapse tends to show up before you feel anything.
NCI describes the pattern over time. The speed of growth, measured by how fast the monoclonal protein doubles, increases with each relapse. Periods of remission get shorter. That is a reason to plan ahead, not a reason to rush.
Ask what your own numbers have done over the last three tests. A single value means much less than a trend.
Numbers alone, or symptoms too
This is the decision that matters most right now. NCI says the start of treatment may be delayed when the disease is moving slowly and you are well.
It also describes a group whose disease never responded but stayed stable, with an outlook as good as those who did respond. Those people can stop treatment until the myeloma starts moving again.
So ask directly whether you need treatment today, or watching. Ask what change would tip the answer.
The findings that mean treat now
NCI lists what counts as active disease. High calcium. Rising creatinine or falling kidney function. Anemia with hemoglobin under 10.0 g/dL. New bone lesions. Very high plasma cells in the marrow. A light chain ratio of 100 or more.
Ask which of these you have. Ask which are being checked at each visit.
Tests that get repeated at relapse
Ask whether the marrow biopsy will be done again, with chromosome testing. Ask whether imaging is needed to look for new bone lesions.
NCI describes myeloma that occasionally changes character at relapse and forms tumors outside the marrow. Scanning is how that is found.
Treating with the same drugs again
There is a specific rule of thumb in NCI's summary. When relapse happens a year or more after the first treatment, the same drugs can sometimes be given a second time.
For people who are fit, NCI says a response to repeat treatment can be consolidated with a transplant.
Questions when the numbers rise
- Is this a rise in numbers only, or do I have symptoms?
- Which of the active-disease findings do I have?
- Do we confirm the rise on a repeat test first?
- Should my marrow biopsy and chromosome tests be redone?
- Do I need scans to look for new bone lesions?
- Has it been a year or more since my last treatment?
- Is a transplant part of the plan this time?
When to get help sooner
- Call 911 or go to an emergency department if you have new weakness in your arms or legs, new numbness in your legs or groin, trouble walking, or new loss of bladder or bowel control. Myeloma weakens bone in the spine. Pressure on the spinal cord is an emergency, and delay costs movement.
- Call 911 or go to an emergency department if severe back or rib pain starts suddenly, especially after a small movement or a minor fall. A bone that breaks easily is part of active myeloma.
- Call your care team immediately, at whatever hour it happens, if you have a temperature of 100.4°F (38°C) or higher, or chills. Infection is common in myeloma, and the drugs used at relapse push the neutrophil count down, so CDC rates a fever on treatment a medical emergency rather than a same-day call. Go to an emergency department if the team cannot be reached quickly.
- Call your care team the same day if you become confused, unusually thirsty, or are vomiting, or if you are passing much less urine. High calcium and failing kidneys are two of the findings that define active disease, and both are treatable.
- Call your care team within a day or two if bone pain is new or steadily worse, if you bruise or bleed easily, or if you are getting more tired and breathless.
Related pages
Cancer Staging and Biomarker Testing explain the terms that come up when multiple myeloma relapses. Clinical Trial vs Standard Treatment, Palliative Care, and Questions to Ask Your Doctor cover the choices that follow a multiple myeloma relapse.
Where this comes from
These questions were drawn from current patient guidance for multiple myeloma:
Words to know
Tap any term to see what it means.
Common questions
My paraprotein is rising. Do I have to start treatment now?
Not necessarily. NCI says the onset of therapy may be delayed because of slow disease progression and good performance status. Ask whether you meet the criteria for active disease, ask what your last three results have done as a trend rather than as single values, and ask what change would tip the answer toward treating.
Which findings mean treat now?
NCI's list of active disease: hypercalcemia more than 1 mg/dL above the reference range, creatinine above 2 mg/dL or creatinine clearance under 40 mL/min, anemia with hemoglobin below 10.0 g/dL, one or more bone lesions on skeletal imaging, clonal plasma cells at 60% or more of the marrow, or an involved to uninvolved serum free light chain ratio of 100 or more.
Can I have the same drugs again?
Sometimes. NCI states that when relapse occurs 1 year or more after initial therapy, the same drugs can be administered a second time, and that in fit patients a response to reinduction may be consolidated with a transplant. Ask how long it has been since your last treatment, because that interval is part of the decision.
Which tests get repeated at relapse?
Ask whether the marrow biopsy will be redone with chromosome testing, and whether imaging is needed to look for new bone lesions. NCI notes that myeloma cells can dedifferentiate at relapse and form extramedullary plasmacytomas — tumors outside the marrow — which scanning is how you find.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-11 what this meansLast updated: 2026-08-19Next planned review: 2028-07-30
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- What Is Multiple Myeloma?
- Cancer Staging: What the Stage Means
- Biomarker Testing and Precision Medicine
- Getting a Second Opinion After a Diagnosis
- Questions to Ask About Multiple myeloma Treatment
- Multiple myeloma: Relapsed or Refractory Questions
- Multiple myeloma Survivorship Follow-Up Questions
- Coping With Fear of Recurrence
Still have questions?
Educational answers, plain language
Free to print and share